Resection rate and outcome of pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Oskarsdottir, Gudrun N
Isaksson, Helgi J
MetadataShow full item record
CitationJ Thorac Oncol 2012, 7(7):1164-9
AbstractThe proportion of patients with non-small-cell lung cancer (NSCLC) who undergo surgery with curative intent is one measure of effectiveness in treating lung cancer. To the best of our knowledge, surgical resection rate (SRR) for a whole nation has never been reported before. We studied the SRR and surgical outcome of NSCLC patients in Iceland during a recent 15-year period. This was a retrospective study of all pulmonary resections performed with curative intent for NSCLC in Iceland from 1994 to 2008. Information was retrieved from medical records and from the Icelandic Cancer Registry. Patient demographics, postoperative tumor, node, metastasis stage, overall survival, and complication rates were compared over three 5-year periods. Of 1530 confirmed cases of NSCLC, 404 were resected, giving an SRR of 26.4%, which did not change significantly during the study period. Minor and major complication rates were 37.4% and 8.7%, respectively. Operative mortality rates were 0.7% for lobectomy, 3.3% for pneumonectomy, and 0% for lesser resection. Five-year survival after all procedures was 40.7% and improved from the first to the last 5-year period (34.8% versus 43.8%, p = 0.04). Five-year survival for stages I and II together was 46.8%, with no significant change in stage distribution between periods. Five-year survival after pneumonectomy was 22.0%, which was significantly lower than for lobectomy (44.6%) and lesser resection (40.7%) (p < 0.005). Unoperated patients had a 5-year survival of 4.8%, as compared to 12.4% for all the NSCLC patients together. Compared with most other published studies, the SRR of NSCLC in Iceland is high. Short-term outcome is good, with a low rate of major complications and an operative mortality of only 1.0%. Five-year survival improved significantly over the study period.
RightsArchived with thanks to Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
- Lobectomy for non-small cell lung carcinoma: a nationwide study of short- and long-term survival.
- Authors: Oskarsdottir GN, Halldorsson H, Sigurdsson MI, Fridriksson BM, Baldvinsson K, Orrason AW, Jonsson S, Planck M, Gudbjartsson T
- Issue date: 2017 Jul
- Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
- Authors: Kasprzyk M, Dyszkiewicz W, Piwkowski C, Brudlo M, Galecki B, Gabryel P, Gasiorowski L
- Issue date: 2013
- Surgical resection and long-term survival for octogenarians who undergo surgery for non-small-cell lung cancer.
- Authors: Dillman RO, Zusman DR, McClure SE
- Issue date: 2009 Mar
- The prognostic factors of resected non-small cell lung cancer with chest wall invasion.
- Authors: Lee CY, Byun CS, Lee JG, Kim DJ, Cho BC, Chung KY, Park IK
- Issue date: 2012 Jan 12
- Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer.
- Authors: Hung JJ, Jeng WJ, Hsu WH, Huang BS, Wu YC
- Issue date: 2012 Feb